Food As a Medicine Market to reach US$11.51 billion by 2031, Functional Foods segment holds 46.5% Market Share, North America led 39% share of Global Market .

Leander, Texas-Dec -01-2025
The Global Food as a Medicine Market reached US$4.71 billion in 2023 and is expected to reach US$11.51 billion by 2031, growing at a CAGR of 12.2 % during the forecast period 2024-2031.

Food as a medicine refers to prioritizing food and diet in an individual's health plan to prevent, reduce, or treat disease symptoms. The "food as a medicine" approach to health management challenges the foundation of conventional medicine, which depends primarily on technological medical developments to treat health and disease using pharmaceutical medications. Using "food as a medicine" may lower healthcare expenses by potentially reducing illness severity through improved labwork, fewer drugs, and fewer hospitalizations.

A large number of educated and knowledgeable consumers prefer food as a medicine approach over medications, which include drugs and other treatments. For instance, according to a study by the Food Safety Net Services (FSNS) in May 2023, 55% of customers are willing to pay a premium for food that can act as medicine, improving their health and well-being.

Download your exclusive sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/food-as-a-medicine-market?pratik 

United States Funding Announcement:-

✅ October 2025: The U.S. Food as a Medicine market reached $11.51 billion in valuation, with leading companies and startups securing significant funding to innovate functional foods targeting chronic disease management and preventive healthcare nutrition. Investments have been driven by growing consumer demand for health-focused food products and integration with healthcare systems.

Japan Funding Announcement:-
✅ September 2025: Japan's Meiji Holdings announced funding and launch for functional dairy and nutritional beverages enriched with probiotics and prebiotics, emphasizing gut health and immunity as part of daily diets.

✅ Earlier 2025: The Japanese medical foods market, valued at about $1.07 billion in 2024, is expanding with increasing government and private funding incentives toward specialized nutrition products for aging populations and chronic disease management, aligning with national health campaigns aimed at disease prevention through diet.

Recent Mergers & Acquisitions

→ NSF International acquired Cambium Analytica (Oct 7, 2025). Deal expands NSF's analytical testing & product development capabilities for natural food, beverage, and dietary-supplement brands (amount undisclosed).

→ Umoja Health acquired Virtual Health Partners (VHP) and its VHPGo® platform (Nov 4, 2025). Acquisition integrates VHP's virtual nutrition/telehealth tools with Umoja's food logistics and medically-tailored food programs to scale food-as-medicine offerings (amount undisclosed).

→ HappyCow (vegan/plant-based discovery platform) changed ownership (early Nov 2025; reported Nov 3-11, 2025). New owner plans a tech rebuild and global expansion - relevant to plant-based/health food ecosystems that overlap with food-as-medicine trends (terms not publicly disclosed).

→ Heart To Home Meals announced supply-chain expansion and reported an acquisition (reported Nov 20, 2025) as part of strengthening its production/specialty meal capabilities (reporting indicates an acquisition of Oaky / supply-chain moves; amount undisclosed). This supports scaling of medically tailored / therapeutic meal operations

Market Segmentation

Segmentation by Product Type
→ Functional Foods -46.5% Market Share
This segment includes nutrient-enriched foods such as fortified grains, probiotics, omega-rich products, and plant-based functional snacks. Functional foods dominate the market due to rising consumer preference for daily nutrition solutions that prevent chronic diseases and support long-term wellness.

→ Dietary Supplements - 39.2% Market Share
This includes vitamins, minerals, herbal extracts, botanicals, and immune-boosting capsules or powders. The segment grows strongly as consumers seek convenient, concentrated forms of therapeutic nutrition for immunity, gut health, inflammation, and cognitive support.

→ Medicinal Foods -14.3% Market Share
These are specialized dietary products formulated for disease-specific conditions such as diabetes, GI disorders, metabolic health, and malnutrition. Though smaller in share, this category is expanding rapidly due to clinical adoption and physician-led recommendations.

Segmentation by Source
→ Plant-Based Products 58.6% Market Share
Derived from fruits, vegetables, herbs, grains, and botanicals, this segment leads due to clean-label trends, rising vegan preferences, and evidence supporting plant-based therapeutic benefits. Growth is supported by strong consumer trust in natural, minimally processed ingredients.

→ Animal-Based Products - 41.4% Market Share
This includes omega-3 from fish oils, collagen, dairy-based formulations, and protein-rich therapeutic foods. While secondary in share, animal-derived medicinal foods remain essential for high-absorption nutrients and medical-grade formulations.

"Secure your 30% year-end discount - get this report before the offer expires."
:https://www.datamintelligence.com/buy-now-page?report=food-as-a-medicine-market?pratik ((Purchase 2 or more Repots and get 50% Discount)

Regional insights:-

North America -39% share
North America (led by the U.S.) is the largest regional market for food-as-medicine solutions. Growth is driven by policy momentum (government & payer pilots, Medicare/Medicaid pilots, and high clinical-nutrition spending), large medically-tailored-meal programs, strong venture / corporate investment in nutrition startups, and ready adoption by health systems. The U.S. holds the bulk of regional revenue and clinical activity.

• Asia-Pacific - 33% share
Asia-Pacific is the fastest-expanding regional contributor to the FAM market. Rapid urbanization, rising chronic-disease burden, increasing healthcare spending, and broader retail adoption of functional/medical foods in China, Japan, South Korea, India and Southeast Asia are the main drivers. Several reports show APAC expanding its share as manufacturers localize medically-tailored products for large populations.

• Europe - 19% share
Europe is a mature but steadily growing market. Strong public-health systems, established reimbursement pathways for medical nutrition in several countries, and regulatory emphasis on evidence and labelling make Europe an important market for premium, clinically-validated food interventions (e.g., medical foods, FSMPs). Adoption is strongest in Western Europe.

Key Players

Bionova, Nestlé, Primus Pharmaceuticals, Inc., Season Health, Mead Johnson & Company, LLC., SFI Health, Metagenics, Meiji Holdings Co., Ltd., Bitewell and Mealogic.

→ Nestlé (including Nestlé Health Science) is a global leader in medical nutrition, offering a broad range of products that cater to patients with specific nutritional needs. It has significant investments in R&D and innovation for functional foods, medical foods, and health outcome programs, positioning it strongly in both consumer and clinical channels.

→ Metagenics, with an annual revenue of approximately USD 297.5 million, specializes in science-based nutritional solutions and personalized lifestyle medicine. It offers medical foods, nutraceuticals, and programs targeted at metabolic and chronic conditions, making it a key healthcare industry player with a strong focus on therapeutic nutrition.

→ Primus Pharmaceuticals, Inc. has annual revenues around USD 17.5 million and focuses on prescription-based medical foods that manage specific dietary needs for metabolic disorders, gastrointestinal diseases, and neurological conditions. It is recognized for product innovation targeting unmet medical needs.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/food-as-a-medicine-market?pratik

Market Drivers:-

→ Rising prevalence of chronic diseases (diabetes, CVD, obesity, GI disorders)
Nutrition-based interventions and medical foods are increasingly used to prevent, manage or slow chronic conditions this creates demand for clinical-grade food products and nutrition programs.

→ Aging population / growing geriatric care needs
Older adults have higher nutritional needs and more chronic conditions, driving uptake of therapeutic nutrition, fortified foods and medical foods.

→ Consumer shift to preventive & wellness-first behaviours
Strong wellness trends (millennials/Gen-Z focus on daily personalized wellness) plus greater interest in foods that deliver measurable health outcomes raise demand for functional and "food-as-medicine" products.

→ Scientific advances enabling personalized nutrition (nutrigenomics, microbiome, data/AI-driven recommendations)
Better evidence, genomics, microbiome research and AI-driven digital platforms let companies design targeted dietary interventions and demonstrate clinical benefit unlocking commercial opportunities.

→ Regulatory recognition & growth of medical/clinical nutrition categories
Expansion and clearer pathways for medical foods, clinical nutrition and reimbursable therapeutic diets encourage industry investment and wider adoption in healthcare settings.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.

This release was published on openPR.